Dermatology · Prairieville, LA
NPI
1952398893
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
17503 Old Jefferson Hwy
Prairieville, LA, 70769
Phone (225) 313-4560
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
3,396 services
Medicare patients, 2024
603
Average age 74
Drug cost, 2024
$988K
1,932 prescriptions
Company payments, 2025
$146K
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William T Massengale was code 17003 (destruction skin lesion), 820 times for 174 patients. In total William T Massengale billed 3,396 services in 59 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 820 | 174 | $4.45 | $3,645 |
| 99213 Office E&M - Established | Office | 520 | 378 | $52.01 | $27K |
| 17110 Destruction Skin Lesion | Office | 342 | 275 | $66.16 | $23K |
| 17000 Destruction Skin Lesion | Office | 321 | 248 | $31.71 | $10K |
| 99214 Office E&M - Established | Office | 164 | 129 | $78.21 | $13K |
| 11102 Skin Biopsy | Office | 145 | 132 | $48.14 | $6,981 |
| 99203 Office E&M - New | Office | 91 | 91 | $60.54 | $5,509 |
| 12032 Wound Repair - All Levels | Office | 37 | 34 | $207.23 | $7,668 |
| 10040 Removal or Shaving of Skin Growth | Office | 33 | 33 | $72.49 | $2,392 |
| 17111 Destruction Skin Lesion | Office | 27 | 24 | $71.41 | $1,928 |
| 11603 Skin Lesion Excision | Office | 23 | 22 | $101.82 | $2,342 |
| 99204 Office E&M - New | Office | 23 | 23 | $83.30 | $1,916 |
| 11103 Skin Biopsy | Office | 21 | 16 | $34.87 | $732 |
| 12053 Wound Repair - All Levels | Office | 17 | 17 | $252.17 | $4,287 |
| 17004 Destruction Skin Lesion | Office | 13 | 11 | $120.80 | $1,570 |
By year: 2022 $168K for 5,756 services; 2023 $163K for 5,016 services; 2024 $133K for 3,396 services.
Medicare prescription drug claims, 2024
In 2024, the drug William T Massengale prescribed most often to Medicare patients was Triamcinolone Acetonide, with 318 prescriptions and refills. In total William T Massengale wrote 1,932 Medicare prescriptions that cost $988K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 318 | 377 | 212 | $4,129 |
| Minoxidil Generic | 209 | 376 | 60 | $1,582 |
| Ketoconazole Generic | 162 | 183 | 80 | $2,431 |
| Hydrocortisone Generic | 140 | 157 | 99 | $957 |
| Clobetasol Propionate Generic | 120 | 129 | 82 | $3,066 |
| Fluconazole Generic | 98 | 148 | 61 | $1,188 |
| Finasteride Generic | 91 | 165 | 27 | $773 |
| Mupirocin Generic | 88 | 89 | 63 | $779 |
| Ivermectin Generic | 68 | 68 | 40 | $19K |
| Doxycycline Hyclate Generic | 62 | 70 | 49 | $731 |
| Spironolactone Generic | 60 | 94 | 13 | $387 |
| Doxycycline Monohydrate Generic | 40 | 43 | 25 | $553 |
| Otezla Apremilast | 35 | 37 | Under 11 | $181K |
| Valacyclovir Valacyclovir Hcl | 33 | 51 | 25 | $1,277 |
| Tretinoin Generic | 28 | 35 | 13 | $2,339 |
Brand drugs: 174 claims; generic drugs: 1,758 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William T Massengale $146K ($146K in general payments such as food, travel and fees) from 21 companies. The largest payer was Galderma Laboratories, L.P. with $55K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 59 | $55K |
| Lilly USA, LLC LLY | 58 | $48K |
| Abbvie Inc. ABBV | 82 | $27K |
| Janssen Biotech, Inc. JNJ | 25 | $13K |
| Arcutis Biotherapeutics, Inc. ARQT | 12 | $2,158 |
| Genzyme Corporation SNY | 14 | $419 |
| Pfizer Inc. PFE | 25 | $277 |
| UCB, Inc. UCB.BR | 9 | $249 |
| LEO Pharma Inc. | 12 | $238 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $210 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.